Health officials across the Americas are grappling with a growing crisis: bacteria are becoming increasingly resistant to the antibiotics doctors rely on when all other treatments have failed. According to the Pan American Health Organization, this trend has accelerated steadily over the past decade, limiting options for treating serious infections throughout the region and the Caribbean.
PAHO’s data reveal the scope of the problem through surveillance networks tracking bacterial resistance patterns. Resistance to carbapenems—a critical class of antibiotics used as a last resort—has climbed sharply in Klebsiella pneumoniae, jumping from roughly 15 percent in 2015 to 26 percent in 2024 based on data from 15 countries. Escherichia coli showed a smaller but still concerning rise from three to five percent over the same period. Most alarming, Acinetobacter baumannii demonstrated median resistance to carbapenems reaching 77 percent across seven reporting countries.
The consequences extend far beyond hospital walls. While resistant bacteria pose particular dangers to vulnerable patients in healthcare settings, these microorganisms also threaten communities by making routine infections—such as urinary tract infections—harder to treat and increasing hospitalization risks. Pilar Ramón Pardo, chief of PAHO’s Special Programme on Antimicrobial Resistance, emphasized the urgency of the moment, calling for stronger surveillance systems, better infection prevention, and expanded access to new antibiotics used responsibly.
Addressing the crisis requires a coordinated regional approach that spans human, animal, and environmental health. PAHO works through its Pan American Center for Foot-and-Mouth Disease and Veterinary Public Health to combat resistance across sectors, recognizing that resistant bacteria circulate freely among animals, food, people, and the environment. Manuel Sánchez Vázquez, the center’s director, stressed that countries must share information and strengthen surveillance to detect and prevent the spread of resistant pathogens early.
These efforts are anchored in PAHO’s new Plan of Action on Antimicrobial Resistance spanning 2027 to 2031, which member states approved in September. The plan underscores a fundamental reality: without urgent action to preserve antibiotic effectiveness and expand treatment options, hospital-acquired infections will become increasingly difficult to manage, posing mounting risks to patients throughout the region.
Antimicrobial resistance occurs when bacteria, viruses, fungi, and parasites no longer respond to medicines designed to treat them. The issue is being highlighted during World Antimicrobial Resistance Awareness Week (November 18–24, 2026) under the theme ‘One Health, One Action: Act Now to Prevent AMR,’ which emphasizes coordinated action across human, animal, and environmental health sectors.
The Caribbean is explicitly included in PAHO’s warning about rising antibiotic resistance, making this a direct health threat to the region’s hospitals, clinics, and communities. As a major public health challenge affecting treatment options for serious infections, this trend has immediate implications for healthcare systems and patients throughout Caribbean nations.
